GlassScriptPhysician profile
Avinashi Arun Kumar
NPI 1326375999
$936.16
in general payments reported to CMS, 2019-2025
14 companies · $678 in 2025
The $678 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $258 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $269.18 | 2025 | Repatha, Krystexxa, Otezla |
| Novo Nordisk INC | $147.02 | 2024-2025 | Ozempic, Rybelsus |
| Corcept Therapeutics | $144.46 | 2025 | Korlym |
| Edwards Lifesciences Corporation | $139.50 | 2024 | Sapien 3 Ultra Resilia |
| Exact Sciences Corporation | $39.88 | 2024-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $33.79 | 2025 | Veozah |
| Medtronic, INC. | $30.00 | 2025 | Closurefast |
| Abbott Laboratories | $24.28 | 2024 | Octrode |
| Boston Scientific Corporation | $23.24 | 2025 | General - Brady |
| Abiomed | $23.01 | 2024 | Impella |
| Kowa Pharmaceuticals America, INC. | $22.27 | 2025 | Zoryve |
| Astrazeneca Pharmaceuticals LP | $14.81 | 2025 | Airsupra |
| Lilly USA, LLC | $13.41 | 2024 | Mounjaro, Zepbound |
| Advanced Oxygen Therapy INC. | $11.31 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avinashi Arun Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.